Alembic Pharma share price gains 5% after USFDA okays seizures drug 0 03.10.2024 09:50 Business Standard Alembic Pharma share price surged after the United States Food and Drug Administration (USFDA) gave final approval for Lamotrigine ExtendedRelease Tablets USP, 200 mg, 250 mg, and 300 mg. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
